论文部分内容阅读
目的观察联合麝香保心丸佐治冠心病的临床疗效。方法选取医院冠心病患者66例,依据治疗方式不同分为治疗组34例和对照组32例,对照组给予常规治疗,治疗组在此基础上给予麝香保心丸治疗,随访3个月,观察治疗结果进行比较是否存在显著的优异性。结果经过3个月治疗和回访,治疗组综合总有效率为85.30%明显高于对照组的75.00%(P<0.05);治疗组心绞痛发作频率低于对照组,持续时间短于对照组(P<0.05);治疗组C反应蛋白和D-二聚体水平均显著低于对照组,差异均有统计学意义(P<0.05)。结论常规西药长期联合口服麝香保心丸治疗冠心病疗效显著优于常规西药治疗。
Objective To observe the clinical efficacy of combined musk pill in treating coronary heart disease. Methods Sixty-six patients with coronary heart disease in our hospital were selected and divided into treatment group (34 cases) and control group (32 cases). Patients in control group were treated with “Shexiang Baoxin Pill” for 3 months. The results of the treatment were compared whether there is a significant superiority. Results After 3 months of treatment and follow-up, the total effective rate was 85.30% in the treatment group and 75.00% in the control group (P <0.05). The frequency of angina pectoris in the treatment group was lower than that in the control group, and the duration was shorter than that in the control group <0.05). The levels of C-reactive protein and D-dimer in the treatment group were significantly lower than those in the control group (P <0.05). Conclusion Conventional western medicine long-term combined oral administration of musk heart pills is superior to traditional western medicine in the treatment of coronary heart disease.